PHS
RCKT icon

PFM Health Sciences’s Rocket Pharmaceuticals RCKT Stock Holding History

PFM Health Sciences’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-238,762
Closed -$4.74M – 84
2023
Q2 		$4.74M Buy
+238,762
New +$4.82M 0.18% 69

Other funds holding RCKT

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

PFM Health Sciences's RCKT Position: Q3 2023 in Review

PFM Health Sciences sold out of Rocket Pharmaceuticals (RCKT) in Q3 2023, closing a stake of 238,762 shares — an estimated $4.74M sold.

PFM Health Sciences first reported a position in RCKT in Q2 2023 and held it in 1 quarter. The position peaked at $4.74M in Q2 2023. 175 funds tracked by Wall St. Rank hold RCKT as of Q3 2023.

  • PFM Health Sciences reported no remaining Rocket Pharmaceuticals position as of Q3 2023 after selling out during the quarter.
  • PFM Health Sciences sold 238,762 Rocket Pharmaceuticals shares in Q3 2023, an estimated $4.74M.
  • PFM Health Sciences first reported a position in Rocket Pharmaceuticals in Q2 2023 and held it in 1 quarter.
  • PFM Health Sciences's Rocket Pharmaceuticals position peaked at $4.74M in Q2 2023.
  • 175 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q3 2023.

Based on PFM Health Sciences's 13F filing for Q3 2023, filed 14 Nov 2023.